
There Are Two New Drugs to Treat Gonorrhea
The FDA approved two new drugs to treat gonorrhea The new drugs—gepotidacin and zoliflodacin—are both new kinds of antibiotics and represent the first completely new treatment options in over thirty years.
In contrast to the encouraging news from the most recent report on sexually transmitted infection (STI) rates in the U.S., a report published by the European Centre for Disease Prevention and Control (ECDC) shows a striking rise in STIs across the Atlantic.
The new data, which covers reported cases of STIs in 2023 across 29 countries in the European Union/European Economic Area (EU/EEA), shows:
As in the U.S., public health officials in Europe are particularly concerned about congenital syphilis—when the infection passes to infants during pregnancy. Syphilis during pregnancy can lead to miscarriage or stillbirth, and infants born with syphilis can have lifelong health issues. But timely testing and treatment can prevent this.
The EU/EEA saw syphilis cases in newborns increase slightly, from 73 in 2022 to 78 in 2023. In the U.S., 3,800 cases were reported in 2023, the highest number reported in one year since 1994, according to the Centers for Disease Control and Prevention (CDC). Syphilis testing is a critical part of prenatal care. Experts believe testing and treatment of pregnant individuals would prevent nearly 90% of congenital syphilis cases.
Data like this don’t reveal why STIs are increasing, but public health authorities around the globe point to a combination of factors. These include increased testing with more sophisticated technologies, fewer young people consistently using condoms, and the erosion of public health resources that support STI control programs. Less discussed, but still important, is the tremendous impact of shame and stigma on accessing sexual health care.

The FDA approved two new drugs to treat gonorrhea The new drugs—gepotidacin and zoliflodacin—are both new kinds of antibiotics and represent the first completely new treatment options in over thirty years.

The American Cancer Society (ACS) released new recommendations for cervical cancer screening that focus on HPV testing and approve the use of self-collected samples. The recommendations also clarify the age at which screening should start and stop.

Public health officials in England announced that they have identified a new combined type of mpox. Tests show the virus was a unique mix of the two known types of mpox and experts are concerned about what this means for future spread of the virus.

A committee that advises the Centers for Disease Control and Prevention (CDC) made an alarming change to the recommendations for the hepatitis B vaccine that will leave some infants unprotected.

The Centers for Disease Control and Prevention (CDC) recently made striking changes to its online information about the connection between vaccines and autism that put the agency on the wrong side of science.

A new report from the World Health Organization (WHO) warns of rising levels of drug-resistant gonorrhea. The data comes from reported cases of gonorrhea in 12 countries across five WHO regions.

We’ve known for years that the HPV vaccine works. Now new research shows that widespread vaccination even protects those who haven’t gotten the shot. This study proves that it is possible to reach herd immunity for HPV.

A more serious type of mpox may be spreading California. Three people in the state were hospitalized with the virus.
ASHA believes that all people have the right to the information and services that will help them to have optimum sexual health. We envision a time when stigma is no longer associated with sexual health and our nation is united in its belief that sexuality is a normal, healthy, and positive aspect of human life.
ABOUT
GET INVOLVED
ASHA WEBSITES
GET HELP
© 2025 American Sexual Health Association